I am very pleased to announce, before Qbiotics have done so, that FDA have approved Stelfonta. Cheers
https://www.prnewswire.com/news-releases/fda-approves-first-intratumoral-injection-to-treat-non-metastatic-mast-cell-tumors-in-dogs-301173908.html
FDA NEWS RELEASEFDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in DogsShareTweetEmailFor Immediate Release:November 16, 2020Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog’s skin (subcutaneous), in particular areas of a dog’s leg. Stelfonta is injected directly into the MCT (intratumoral injection). Stelfonta works by activating a protein that spreads throughout the treated tumor, which disintegrates tumor cells.
Etc
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-142
-
- There are more pages in this discussion • 1,133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online